(Q40287559)

19 September 2017

A prospective, randomized study of empirical antifungal therapy for the treatment of chemotherapy-induced febrile neutropenia in children (English)

1 reference

chemotherapy-induced febrile neutropenia

19 September 2017

0 references

Simone Cesaro

2

0 references

author name string

Désirée Caselli

1

1 reference

19 September 2017

Ottavio Ziino

3

1 reference

19 September 2017

Pietro Ragusa

4

1 reference

19 September 2017

Alfredo Pontillo

5

1 reference

19 September 2017

Anna Pegoraro

6

1 reference

19 September 2017

Nicola Santoro

7

1 reference

19 September 2017

Giulio Zanazzo

8

1 reference

19 September 2017

Vincenzo Poggi

9

1 reference

19 September 2017

Mareva Giacchino

10

1 reference

19 September 2017

Susanna Livadiotti

11

1 reference

19 September 2017

Fraia Melchionda

12

1 reference

19 September 2017

Marcello Chiodi

13

1 reference

19 September 2017

Maurizio Aricò

14

1 reference

19 September 2017

language of work or name

English

0 references

publication date

10 May 2012

1 reference

British Journal of Haematology

19 September 2017

1 reference

19 September 2017

158

1 reference

19 September 2017

2

1 reference

19 September 2017

249-255

1 reference

Aspergillosis in children with cancer: A 34-year experience

19 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09156.X

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09156.X

Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09156.X

Fungal Infections in Children With Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09156.X

Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09156.X

Invasive aspergillosis in a paediatric haematology department: a 15-year review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09156.X

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09156.X

Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09156.X

Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09156.X

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09156.X

A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09156.X

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09156.X

The epidemiology of sepsis in the United States from 1979 through 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09156.X

Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09156.X

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09156.X

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09156.X

Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09156.X

Pediatric aspergillosis: disease and treatment differences in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09156.X

Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09156.X

Epidemiology of paediatric invasive fungal infections and a case-control study of risk factors in acute leukaemia or post stem cell transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09156.X

10.1111/J.1365-2141.2012.09156.X

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference